Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40012771
Localisation
Switzerland
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
08/01/2026
Statut
Classification
1.5°C
Année cible
2034
Statut
Targets set
Classification
1.5°C
Année cible
2050
Overall Net-Zero Target: Ferring Group commits to achieve net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets: Ferring Group commits to reduce absolute scope 1 and 2 GHG emissions 58.8% by 2034 from a 2023 base year. Ferring Group also commits that 74% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by 2030. Long-Term Targets: Ferring Group commits to reduce absolute scope 1 and 2 GHG emissions 90.0% by 2050 from a 2023 base year. Ferring Group also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, capital goods, upstream transportation and distribution, waste generated in operations, business travel and end-of-life treatment of sold products 90.0% within the same timeframe.
Statut
Targets setAnnée cible
2050
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
Source : Science Based Targets initiative | Données publiques